Comparison of 18F-FDG PET/CT and 18F-FAPI PET/CT in Systemic Staging of Newly Diagnosed Breast Cancer

被引:0
|
作者
Ji, Bin [1 ]
Li, Wenjia [2 ]
Wang, Wan [2 ]
Min, Kaiyin [1 ]
Yang, Bowen [1 ]
Wan, Qichang [3 ]
Liu, Junzhi [1 ]
Gao, Shi [1 ]
机构
[1] Jilin Univ, Dept Nucl Med, China Japan Union Hosp, Changchun 130033, Peoples R China
[2] Jilin Univ, Dept Breast Surg, China Japan Union Hosp, Changchun 130033, Peoples R China
[3] Guangzhou Med Univ, Affiliated Qingyuan Hosp, Qingyuan Peoples Hosp, Dept Nucl Med, Qingyuan 511500, Peoples R China
关键词
F-18-FAPI PET/CT; F-18-FDG PET/CT; Breast cancer; Systemic staging; Sensitivity;
D O I
10.1016/j.acra.2024.07.058
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: The purpose of this study was to compare the performance of F-18-FAPI PET/CT and F-18-FDG PET/CT in systemic staging of newly diagnosed breast cancer. Methods: Breast cancer patients with initial clinical stage IIB-IIIC who have consequently underwent both F-18-FAPI and F-18-FDG PET/CT from June 2022 to June 2023 were retrospectively analyzed. New clinical stage was assigned to each patient if unsuspected level III axillary and extraaxillary regional lymph node metastases (URNM) and/or distant metastases were disclosed after PET/CT. Sensitivity for both tests was calculated on patient basis and lesion basis using histology or follow-up imaging as reference standard. Results: 38 patients were included. The overall upstaging rate was 47.4% for F-18-FAPI PET/CT (18/38) and 34.2% for F-18-FDG PET/CT (13/38). The rate of distant metastases disclosed by F-18-FAPI PET/CT was 5.5% in stage IIB patients, 30% in stage IIIA patients, 50% in stage IIIB patients, and 75% in stage IIIC patients. On patent-based analysis, the sensitivity of F-18-FAPI PET/CT was significantly different from that of F-18-FDG PET/CT in detecting URNM [100% (13/13) vs 53.8% (7/13), (P = 0.031)], but not for distant metastases [100% (10/10) vs 90% (9/10), (P = 1.000)]. On lesion-based analysis, the sensitivity of F-18-FAPI PET/CT was significantly higher than that of F-18-FDG PET/CT in detecting URNM [97.6% (41/42) vs 52.4% (22/42), (P < 0.001)] and distant metastases [98.1% (51/52) vs 67.3% (35/52), (P < 0.001)]. Conclusion: F-18-FAPI PET/CT leads to significant upstaging in newly diagnosed breast cancer, in a rate higher than F-18-FDG PET/CT. The significantly higher lesion-based sensitivity in unsuspected metastases implies a future role of F-18-FAPI PET/CT in evaluation of metastatic disease burden. (c) 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [31] 18F-FDG PET/CT in Initial Staging of Gastric Cancer
    Filik, M.
    Kir, K. M.
    Aksel, B.
    Ozkan, E.
    Kucuk, N. O.
    Ibis, E.
    Akgul, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S584 - S584
  • [32] Gallbladder cancer staging with 18F-FDG PET-CT
    Ramos-Font, C.
    Santiago Chinchilla, A.
    Rodriguez-Fernandez, A.
    Rebollo Aguirre, A. C.
    Gomez Rio, M.
    Llamas Elvira, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2009, 28 (02): : 74 - 77
  • [33] 18F-FDG PET/CT in the Preoperative Staging of Endometrial Cancer
    Gutta, A.
    Pilloy, W. J.
    Mosehle, T.
    Nemutaduni, P. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S500 - S500
  • [34] 18F-AlF-LNC1007 in the evaluation of Breast cancer:comparison with 18F-FDG/18F-FAPI-04 PET/CT
    Gao, Haiyan
    Zhang, Wei
    Zhang, Jingjing
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [35] Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma
    Gundogan, Cihan
    Komek, Halil
    Can, Canan
    Yildirim, Ozgen Ahmet
    Kaplan, Ihsan
    Erdur, Erkan
    Poyraz, Kerem
    Guzel, Yunus
    Oruc, Zeynep
    Cakabay, Bahri
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (01) : 64 - 72
  • [36] Assessing the Usefulness of 18F-FDG PET/CT in Staging Primary Breast Cancer
    Escabias, C.
    Santos, I.
    Coronado, M.
    Mendez, R.
    Hernandez, I.
    Coya, J.
    Martin-Curto, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S231 - S231
  • [37] 18F-FES PET/CT influences the staging and management of newly diagnosed Oestrogen Receptor positive Breast Cancer Patients: A Retrospective Comparative Study with 18F-FDG PET/CT
    Liu, Cheng
    Gong, Chengcheng
    Liu, Shuai
    Xu, Xiaoping
    Yuan, Huiyu
    Zhang, Yongping
    Yang, Zhongyi
    Wang Biyun
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [38] Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to 18F-FDG PET/CT
    Zheng, Dong
    Liu, Yi
    Liu, Jiajin
    Li, Ke
    Lin, Mu
    Schmidt, Holger
    Xu, Baixuan
    Tian, Jiahe
    CANCER IMAGING, 2020, 20 (01)
  • [39] 18F-AlF-NOTA-FAPI PET/CT in the evaluation of gastric, liver, and pancreatic cancer and comparison with 18F-FDG PET/
    Xu, W.
    Cai, J.
    Pang, Y.
    Sun, L.
    Chen, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S497 - S497
  • [40] Intraindividual comparison of 68Ga-FAPI PET/CT with 18F-FDG PET/CT for imaging of cancer of the cervix
    Mokoala, Kgomotso
    Maserumule, Letjie
    Mokgoro, Neo
    Ndlovu, Honest
    Ismaila, Aisha
    Ebenhan, Thomas
    Zeevaart, Jan Rijn
    Sathekge, Mike
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65